Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Revvity, Inc. Common Stock (NY:RVTY)

103.67 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jul 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Revvity, Inc. Common Stock

< Previous 1 2 3 Next >
ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Revvity Q2 Revenue Up 4 Percent
Via The Motley Fool
Topics Economy
Revvity (NYSE:RVTY) Surprises With Q2 Sales
Life sciences company Revvity (NYSE:RVTY) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 4.1% year on year to $720.3 million. The company expects the full year’s revenue to be... 
Via StockStory
A Glimpse of Revvity's Earnings Potential
 
Via Benzinga
Peering Into Revvity's Recent Short Interest
 
Via Benzinga
Is the Market Bullish or Bearish on Revvity?
 
Via Benzinga
Earnings Scheduled For July 28, 2025
 
Via Benzinga
What To Expect From Revvity’s (RVTY) Q2 Earnings
Life sciences company Revvity (NYSE:RVTY) will be reporting results this Monday morning. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
Monday's session: gap up and gap down stock in the S&P500 index
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Monday to uncover the stocks that are gapping in the S&P500 index. 
Via Chartmill
Thermo Fisher, Exact Sciences, Integer Holdings, Revvity, and 10x Genomics Shares Are Falling, What You Need To Know
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like... 
Via StockStory
Topics Lawsuit World Trade
Reflecting On Research Tools & Consumables Stocks’ Q1 Earnings: Revvity (NYSE:RVTY)
Let’s dig into the relative performance of Revvity (NYSE:RVTY) and its peers as we unravel the now-completed Q1 research tools & consumables earnings season. 
Via StockStory
Topics Economy
3 Low-Volatility Stocks in the Doghouse
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
What 9 Analyst Ratings Have To Say About Revvity
 
Via Benzinga
1 Profitable Stock with Exciting Potential and 2 to Be Wary Of
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
3 Healthcare Stocks Skating on Thin Ice
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
3 Mid-Cap Stocks with Questionable Fundamentals
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with... 
Via StockStory
Stay informed with the top movers within the S&P500 index on Wednesday.
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Wednesday as we examine the latest happenings in today's session. 
Via Chartmill
What's going on in today's session: S&P500 movers
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
Which S&P500 stocks are gapping on Wednesday?
Looking for the S&P500 stocks that are experiencing notable gaps on Wednesday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session. 
Via Chartmill
Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides... 
Via StockStory
Topics Government Stocks World Trade
RVTY Q1 Earnings Call: Resilient Performance Amid Academic and Tariff Headwinds, Software and Diagnostics Shine
Life sciences company Revvity (NYSE:RVTY) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 2.3% year on year to $664.8 million. The company’s full-year revenue... 
Via StockStory
Topics Economy World Trade
3 S&P 500 Stocks in the Doghouse
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
1 Safe-and-Steady Stock with Exciting Potential and 2 to Avoid
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
What's going on in today's pre-market session: S&P500 movers
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. 
Via Chartmill
Life Science Tools Maker Revvity Delivers Strong Q1 Earnings Despite Evolving Macroeconomic Backdrop
Revvity posts strong Q1 results with Life Sciences and Diagnostics growth, lifts 2025 sales guidance, and expects higher adjusted operating margins. 
Via Benzinga
Revvity Q1 Earnings Surpass Street Estimates, Investors Cheer 2025 Revised Revenue Guidance
For the full year, Revvity raised its revenue guidance to a range of $2.83 billion to $2.87 billion to reflect recent changes in foreign currency exchange rates. 
Via Stocktwits
Revvity (NYSE:RVTY) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds Expectations
Life sciences company Revvity (NYSE:RVTY) announced better-than-expected revenue in Q1 CY2025, with sales up 2.3% year on year to $664.8 million. The company’s full-year revenue guidance of $2.85... 
Via StockStory
Revvity (RVTY) Q1 Earnings Report Preview: What To Look For
Life sciences company Revvity (NYSE:RVTY) will be reporting results tomorrow before market hours. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
Earnings Scheduled For April 28, 2025
 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.